Minervax
VerifiedEngaged in clinical development of a Group B Streptococcal vaccine targeting pregnant women for the prevention of life-threatening infections in newborns. Learn more
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$238—356m (Dealroom.co estimates Oct 2023.)
Company register number 32673287
Hellerup Capital Region of Denmark (HQ)